ArticleInternational journal of laboratory hematology2026
Evaluating the Quality Performance of Sysmex and Mindray Hematology Analyzers for Blood Cell Counting Based on External Quality Assessment Data.
Article in International journal of laboratory hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aims to evaluate the analytical performance of Sysmex and Mindray hematology analyzers for white blood cell (WBC), red blood cell (RBC), and platelet (PLT) counting. We calculated Z-scores and total allowable error (TEa) based on External Quality Assessment (EQA) data to provide references for laboratory quality improvement.
methodsSysmex and Mindray blood cell analysis systems are categorized into six groups based on instrument models, detection methods, or reagent properties: Sysmex (1), Sysmex (2), Sysmex (3) and Mindray (1), Mindray (2), Mindray (3). EQA data for WBC, RBC, and PLT from the National Center for Clinical Laboratories (NCCL) EQA programs (2020-2024) were collected. Robust means and standard deviations were calculated to determine Z-scores for each Sysmex and Mindray instrument group, assessing bias relative to assigned values. TEa for each instrument group of laboratories participating in the EQA activity (TEa-Lab) was calculated using bias and the robust coefficient of variation (CV). Subsequently, TEa-Lab was compared with the minimum, desirable, and optimal tiers of biological variation -based TEa (TEa-BV) to evaluate the performance specifications of participating laboratories.
resultsThere were 10 instances where the absolute Z-score |Z| for WBC was greater than 2. These were distributed among the groups as follows: Sysmex (1): 0, Sysmex (2): 1, Sysmex (3): 0, Mindray (1): 3, Mindray (2): 3, Mindray (3): 3. For RBC, 22 instances had |Z| greater than 2, distributed as follows: Sysmex (1): 2, Sysmex (2): 3, Sysmex (3): 4, Mindray (1): 6, Mindray (2): 4, Mindray (3): 3. For PLT, 3 instances had |Z| greater than 2, with counts of Sysmex (2): 1, Sysmex (3): 1, Mindray (1): 1. Regarding the comparison TEa, for WBC, all groups, except Mindray (2), which met the desirable standard, achieved the optimal standard. For RBC, the Sysmex (3) group achieved the optimal standard; the Mindray (2) group met only the minimum standard, while the other groups met the desirable standard. For PLT, only the Sysmex (3) and Mindray (3) groups reached the minimum standard. The other peer groups did not meet the minimum standard.
conclusionsZ-scores and TEa-Lab calculated from EQA data provide reliable insights into the performance of hematology analyzers. The performance of Sysmex and Mindray analyzers is stable and demonstrates advanced capabilities. This effectively supports the maintenance of laboratory quality systems and serves as a reference for mutual recognition of test results between laboratories.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.